The application of recombinant human collagen in tissue engineering
Abstract
Collagen is the main structural protein in vertebrates. It plays an essential role in providing a scaffold for cellular support and thereby affecting cell attachment, migration, proliferation, differentiation, and survival. As such, it also plays an important role in numerous approaches to the engineering of human tissues for medical applications related to tissue, bone, and skin repair and reconstruction. Currently, the collagen used in tissue engineering applications is derived from animal tissues, creating concerns related to the quality, purity, and predictability of its performance. It also carries the risk of transmission of infectious agents and precipitating immunological reactions. The recent development of recombinant sources of human collagen provides a reliable, predictable and chemically defined source of purified human collagens that is free of animal components. The triple-helical collagens made by recombinant technology have the same amino acid sequence as human tissue-derived collagen. Furthermore, by achieving the equivalent extent of proline hydroxylation via coexpression of genes encoding prolyl hydroxylase with the collagen genes, one can produce collagens with a similar degree of stability as naturally occurring material. The recombinant production process of collagen involves the generation of single triple-helical molecules that are then used to construct more complex three-dimensional structures. If one loosely defines tissue engineering as the use of…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Collagen mimetic peptides and recombinant human collagen offer reduced immunogenicity and antigenicity compared to animal-derived collagen.
“Collagen mimetic peptides (CMPs) and recombinant human collagen (rhCollagen) offer the benefit of reduced immunogenicity and antigenicity compared to animal-derived collagen, making them less likely to provoke immune responses [37,38,39].”
From Biomaterials in Postoperative Adhesion Barriers and Uterine Tissue Engineering (2025) · cites this paper as [38]
Cites
Ficolins and the lectin complement pathway
Matsushita, M., & Fujita, T. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1800107.x · Cited by 203 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Lutolf, M. P., & Hubbell, J. A. (2005) · Nature Biotechnology · doi:10.1038/nbt1055 · Cited by 4,551 · see citing works
FTIR analysis of natural and synthetic collagen
Riaz, T., Zeeshan, R., Zarif, F., Ilyas, K., Muhammad, N., Safi, S. Z., Rahim, A., Rizvi, S. A. A., & Rehman, I. U. (2018) · Applied Spectroscopy Reviews · doi:10.1080/05704928.2018.1426595 · Cited by 628 · see citing works
Processing of collagen based biomaterials and the resulting materials properties
Meyer, M. (2019) · BioMedical Engineering OnLine · doi:10.1186/s12938-019-0647-0 · Cited by 539 · see citing works
Collagen—emerging collagen based therapies hit the patient
Abou Neel, E. A., Bozec, L., Knowles, J. C., Syed, O., Mudera, V., Day, R., & Hyun, J. K. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.08.010 · Cited by 296 · see citing works
Yee, C., Dickson, K.-A., Muntasir, M. N., Ma, Y., & Marsh, D. J. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.836984 · Cited by 66 · see citing works
Biomaterials in Postoperative Adhesion Barriers and Uterine Tissue Engineering
Fazel Anvari-Yazdi, A., Badea, I., & Chen, X. (2025) · Gels · doi:10.3390/gels11060441 · Cited by 20 · see citing works
Matrix Mediated Viral Gene Delivery: A Review
Steinhauff, D., & Ghandehari, H. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00853 · Cited by 15 · see citing works
- Authors
- Yang, C., Hillas, P. J., B??ez, J. A., Nokelainen, M., Balan, J., Tang, J., Spiro, R., & Polarek, J. W.
- Affiliations
- FibroGen (United States) (US)
- Corresponding author
- Polarek, James W
- Venue
- BioDrugs
- Published
- 2004
- Volume
- 18
- Issue
- 2
- Pages
- 103-119
- ISSN
- 1172-7039 (ISSN-L)
- 1173-8804
- OpenAlex
- W2045285226
- Cited by
- 385
- References
- 1
- Citations by year
- 2026: 15 · 2025: 17 · 2024: 21 · 2023: 27 · 2022: 22 · 2021: 21 · 2020: 19 · 2019: 22 · 2018: 18 · 2017: 22 · 2016: 21 · 2015: 25 · 2014: 11 · 2013: 20 · 2012: 19
- FWCI
- 0.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- BioDrugs (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR 45879, R01AR045879)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Collagen: Extraction and Characterization
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Physical Sciences › Materials Science › Biomaterials › Silk-based biomaterials and applications
- Keywords
- recombinant human collagen, tissue engineering scaffolds, triple-helical collagen, proline hydroxylation, bone regeneration, bone morphogenetic proteins, skin tissue engineering, cartilage tissue engineering, periodontal ligament regeneration, biocompatible scaffolds
- MeSH terms
- Animals, Biocompatible Materials, Collagen, Humans, Recombinant Proteins, Tissue Engineering
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review